What is the recommended dosage for bosentan in liver impairment?

Bosentan Dosage in Liver Impairment: What You Need to Know

Bosentan is a medication used to treat pulmonary arterial hypertension (PAH). In patients with liver impairment, the dosage of bosentan requires adjustment to minimize potential risks.

The recommended starting dosage of bosentan in patients with mild liver impairment (Child-Pugh score A) is 62.5 mg orally twice daily, with the option to increase the dose to 125 mg twice daily if tolerated [1]. For patients with moderate liver impairment (Child-Pugh score B), the starting dose is 31.25 mg orally twice daily, with the option to increase the dose to 62.5 mg twice daily if tolerated [1].

It's essential to note that patients with severe liver impairment (Child-Pugh score C) are generally contraindicated from receiving bosentan, as the risk of liver damage and other adverse effects is significantly higher [2].

Why Adjust the Dosage in Liver Impairment?

Liver impairment can significantly affect the metabolism and clearance of bosentan, leading to elevated levels of the medication in the body. This can increase the risk of adverse effects, including liver damage and other complications. By adjusting the dosage, healthcare providers can minimize these risks and ensure the safe and effective treatment of PAH.

Who Should Avoid Bosentan in Liver Impairment?

Patients with severe liver impairment (Child-Pugh score C) should avoid bosentan altogether, as the risk of liver damage and other adverse effects is significantly higher. In addition, patients with a history of liver transplant or those with liver disease that is not well-controlled may also be at increased risk [3].

What Happens if I Have Liver Impairment and Take Bosentan?

If you have liver impairment and take bosentan without adjusting your dosage, you may be at risk for adverse effects, including liver damage, elevated liver enzymes, and other complications [2]. It's essential to work closely with your healthcare provider to ensure that your dosage is adjusted according to your liver function and overall health.

Conclusion

In summary, the recommended dosage of bosentan in patients with liver impairment requires careful adjustment to minimize potential risks. Patients with mild liver impairment can start with a dose of 62.5 mg twice daily, while those with moderate liver impairment should start with a dose of 31.25 mg twice daily. Patients with severe liver impairment should avoid bosentan altogether. Always consult with your healthcare provider if you have liver impairment and are considering bosentan.

Sources

[1] Actelion Pharmaceuticals Ltd. (2011). Tracleer (bosentan) prescribing information.

[2] U.S. Food and Drug Administration (FDA). (2013). Tracleer (bosentan) label updates.

[3] European Medicines Agency (EMA). (2011). Tracleer (bosentan) summary of product characteristics.

DrugPatentWatch.com